Medtronic received information via literature regarding a comparison of the valve-sparing surgical repair by reimplantation technique of david versus the conventional aortic root replacement with biological or mechanical prostheses in cases of acute debakey type i aortic dissections.All data were prospectively collected from a single center between october 2009 and december 2016.The overall study population included 48 patients (predominantly male; mean age 61 years), 15 patients from the aortic root replacement group were implanted with a medtronic freestyle bioprosthesis (no serial numbers provided).Among all patients in the aortic root replacement group, the 30-day mortality was 20% (4 patients).Multiple manufacturers were noted in the literature; based on the available information, medtronic product was not directly associated with the deaths.Among all patients in the aortic root replacement group, adverse events included: stroke, low cardiac output syndrome, and post-operative blood transfusion.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|